Metrics
Publication
145
Open Access
7
UN Sustainable Development Goals
Education
2000 - 2004
2000 - 2004Post Doctorate of Medicine
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey
1990 - 1995
1990 - 1995Expertise In Medicine
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey
1983 - 1989
1983 - 1989Undergraduate
Istanbul University, Istanbul Medical Faculty, Turkey
Dissertations
2000
2000Post Doctorate of Medicine
Erişkin akut lenfoblastik lösemili hastalarda immunofenotipik özelliklerin prognoz üzerine olan etkilerinin değerlendirilmesi.
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
1995
1995Expertise In Medicine
Akut miyeloid lösemilerin monoklonal antikorlar ve alkalen fosfataz antialkalen fosfataz immünositokimyasal işaretleme tekniği ile immünofenotiplemesi.
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Foreign Languages
C1 Advanced
C1 AdvancedEnglish
Certificates, Courses and Trainings
2002
2002kan bankacılığı
Health&Medicine
Puget Sound Blood Center, University of Washington, Seattle, WA, US
Research Areas
Medicine
Health Sciences
Academic Positions
1995 - Present
1995 - PresentProfessor
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Managerial Experience
2020 - Present
2020 - PresentVice Dean
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Non Academic Experience
1990 - Present
1990 - PresentÖğretim üyesi
İstanbul Üniversitesi, İstanbul Tıp Fakültesi, İç HAstalıkları ABD, Hematoloji Bilim Dalı, Öğretim üyesi
2002 - 2003
2002 - 2003medical scientist
Puget Sound Blood Center, medical scientist
Articles
All (92)
SCI-E, SSCI, AHCI (74)
SCI-E, SSCI, AHCI, ESCI (84)
ESCI (10)
Scopus (84)
TRDizin (20)
2025
20251. Effects of Curcumin on Cancer Stem Cell Markers and P-Glycoprotein-Mediated Drug Resistance in U87 Glioblastoma Cells
NAZLIGÜL E., ÖZERMAN EDİS B., YENEREL M. N., GÜNÇER B.
Sabiad
, vol.8, no.3, pp.137-148, 2025 (Peer-Reviewed Journal)
2025
20252. Therapeutic Challenges and Emerging Strategies for T674I and PTPN11 Mutations in a FIP1L1-PDGFRA-Positive Myeloproliferative Neoplasm: A Case Report
Özkan S. G., Kimiaei A., Safaei S., Karkucak M., Yenerel M. N., Öztürkmen A. Y., et al.
Life
, vol.15, no.3, 2025 (SCI-Expanded)
2025
20253. Impact of COVID-19 on Hematologic Disorders: Clinical Insights and Challenges
ERDEM S., SERT EKİNCİ S., ÖZBALAK M. M., MASTANZADE M., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Istanbul Medical Journal , vol.26, 2025 (ESCI)
2024
20244. Akut Miyeloid Lösemi’li Olgularda inv(3)/t(3;3) ile 7.Kromozomun Anomalilerinin Prognoza Etkisi
BAYRAK TOKAÇ A. G., BAĞATIR G., ERDEM S., ÇEFLE K., ÖZTÜRK Ş., YENEREL M. N., et al.
Manisa Celal Bayar Üniversitesi Eğitim Fakültesi Dergisi
, vol.11, pp.334-339, 2024 (Peer-Reviewed Journal)
2024
20245. Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey.
Kıkılı C. İ., Kıvanç D., Ortaboz D., Şentürk Çiftçi H., Özbalak M. M., Yenerel M. N., et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
, vol.35, no.6, pp.307-315, 2024 (SCI-Expanded, Scopus)
2024
20246. Immunosuppression-Based Lymphoproliferative Disease Features and Parameters Affecting Survival
Göktaş Aydın S., Nalçacı M., Yönal Hindilerden İ., Beşışık S., Yenerel M. N.
Genel Tıp Dergisi , vol.34, no.5, pp.671-679, 2024 (Peer-Reviewed Journal)
2024
20247. INFECTION EVENTS IN MULTIPLE MYELOMA DURING THE EARLY PERIOD OF AUTOLOGOUS STEM CELL TRANSPLANTATION
AMIKISHIYEV S., BEŞIŞIK S., YÖNAL HİNDİLERDEN İ., YENEREL M. N., ÇAĞATAY A. A., ERDEM S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, vol.87, no.3, pp.246-252, 2024 (ESCI)
2024
20248. Expression Patterns of Eighteen Genes Involved in Crucial Cellular Processes in the TP53 Pathway in Multiple Myeloma
Öztan G., Suer İ., Aday A., Ayer M., Öztürk Ş., Çefle K., et al.
GAZI UNIVERSITY JOURNAL OF SCIENCE
, vol.37, no.3, pp.1066-1082, 2024 (ESCI)
2023
20239. CLL-079 The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)
Seyithanoglu D., Nazligul E., Ozbalak M. M., Mastanzade M., Erdem S., Nalcaci M., et al.
CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA
, vol.23, pp.319-320, 2023 (SCI-Expanded)
2023
202310. The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)
Seyithanoglu D., Nazligul E., ÖZBALAK M. M., MASTANZADE M., ERDEM S., NALÇACI M., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, 2023 (SCI-Expanded)
2023
202311. Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey
Dal M. S., Ulu B. U., UZAY A., Akay O. M., Besisik S., Yenerel M. N., et al.
ANNALS OF HEMATOLOGY
, vol.102, no.1, pp.133-140, 2023 (SCI-Expanded)
2023
202312. Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up
Yenerel M. N., de Fontbrune F. S., Piatek C., ŞAHİN F., Fuereder W., Ortiz S., et al.
ADVANCES IN THERAPY
, vol.40, no.1, pp.211-232, 2023 (SCI-Expanded)
2022
202213. Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen
Hindilerden F., Yonal-Hindilerden I., Yenerel M. N., Nalcaci M., Diz-Kucukkaya R.
Hematology Reports
, vol.14, no.3, pp.222-227, 2022 (ESCI)
2022
202214. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia
Erkek E. T., Nazligul E., Nalcaci M., Yenerel M. N.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.38, no.2, pp.319-326, 2022 (SCI-Expanded)
2022
202215. Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience
Özbalak M. M., Güzel Mastanzade M., Özlük Ö., Tiryaki T. O., Erdem S., Özbalak E. P., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.39, no.4, pp.254-261, 2022 (SCI-Expanded)
2021
202116. Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Byrd J. C., Hillmen P., Ghia P., Kater A. P., Chanan-Khan A., Furman R. R., et al.
JOURNAL OF CLINICAL ONCOLOGY
, vol.39, no.31, pp.3441-3454, 2021 (SCI-Expanded)
2021
202117. Raman tweezers as an alternative diagnostic tool for paroxysmal nocturnal hemoglobinuria.
Soysal K. B., Parlatan S., Mastanzade M., Ozbalak M. M., Yenerel M. N., ÜNLÜ M. B., et al.
Analytical methods : advancing methods and applications
, vol.13, no.35, pp.3963-3969, 2021 (SCI-Expanded)
2021
202118. R-CHOP Chemotherapy with a Rituximab Biosimilar (Redditux®) for Patients with de novo Diffuse Large B-cell Lymphoma: First Preliminary Results of a Real-Life Single-Center Experience from Turkey
Özbalak M. M., Mastanzade M., Özlük Ö., Tiryaki T. O., Pınar Özbalak E., Yönal Hindilerden İ., et al.
İstanbul Kanuni Sultan Süleyman Tıp Dergisi , vol.13, no.3, pp.194-198, 2021 (Peer-Reviewed Journal)
2021
202119. First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia
Byrd J. C., Hillmen P., Ghia P., Kater A. P., Chanan-Khan A., Furman R. R., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.21, 2021 (SCI-Expanded)
2021
202120. First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.
Byrd J. C., Hillmen P., Ghia P., Kater A. P., Chanan-Khan A. A. A., Furman R. R., et al.
JOURNAL OF CLINICAL ONCOLOGY
, vol.39, no.15, 2021 (SCI-Expanded)
2021
202121. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis
KEKLİK KARADAĞ F., Yenerel M. N., YILMAZ M., ÜSKÜDAR TEKE H., ÖZKOCAMAN V., Tuglular T. F., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH
, vol.11, no.3, pp.279-285, 2021 (ESCI)
2020
202022. Unusual Presentations of LMNA-Associated Lipodystrophy with Complex Phenotypes and Generalized Fat Loss: When the Genetic Diagnosis Uncovers Novel Features
de Andrade N. X. S., Adiyaman S. C., De Yuksel B., Ferrari C. T., Eldin A. J., Saydam B. O., et al.
AACE Clinical Case Reports
, vol.6, no.2, 2020 (Scopus)
2020
202023. Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia
Ozdemir Z. N., İLHAN O., Ozet G., Falay M., Yenerel M. N., Tuglular T., et al.
CLINICAL LABORATORY
, vol.66, no.9, pp.1709-1715, 2020 (SCI-Expanded)
2020
202024. Retrospective Analysis of Peripheral T-Cell Lymphoma Patients: Single Center 'Real-Life' Experience
Ozbalak M. M., MASTANZADE M., Ozluk O., TİRYAKİ T. O., Hindilerden I. Y., YENEREL M. N., et al.
MEDICAL JOURNAL OF BAKIRKOY
, vol.16, no.4, pp.392-398, 2020 (ESCI)
2019
201925. Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients
Ilhan O., Ozdemir Z. N., Ozet G., Falay M., Yenerel M. N., Tuglular T., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.58, no.5, pp.659-662, 2019 (SCI-Expanded)
2019
201926. Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis
Sariman M., Abaci N., Ekmekci S., Cakiris A., Pacal F., Ustek D., et al.
Balkan medical journal
, vol.36, no.1, pp.23-31, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201927. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., Ozkocaman V., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.36, no.4, pp.230-237, 2019 (SCI-Expanded)
2018
201828. Investigation of ErbB and Insulin Signaling Pathways in the Pathogenesis of Multiple Myeloma
Ozturk D., Coskunpinar E. M., Osmanbasoglu E., ÇETİN G., Yenerel M. N., Ayer M., et al.
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
, vol.56, no.2, pp.109-113, 2018 (ESCI)
2018
201829. Dramatic Reduction of LATS2 Tumor Suppressor Protein Expression in Patients with CLL: Evaluation of LATS2 Levels with Clinical Features and Immunophenotypic Profile
Sert E., Coskunpinar E., Yenerel M. N., Aktan M., Ozturk D., Ozturk O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.28, no.3, pp.137-146, 2018 (SCI-Expanded)
2017
201730. Clinical course and disease burden in patients with paroxysmal nocturnal hemoglobinuria by hemolytic status
Yenerel M. N., Muus P., Wilson A., Szer J.
BLOOD CELLS MOLECULES AND DISEASES
, vol.65, pp.29-34, 2017 (SCI-Expanded)
2017
201731. Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases
Hindilerden F., Yonal-Hindilerden I., Yenerel M. N., Nalcaci M., Diz-Kucukkaya R.
TURKISH JOURNAL OF HEMATOLOGY
, vol.34, no.1, pp.72-80, 2017 (SCI-Expanded)
2016
201632. The frequency of C609T polymorphism in the NQO1 gene and its relation to cytogenetic abnormalities in patients with myelodysplastic syndrome.
Bagatır G., Sırma S. Ö., Palanduz S., Ozturk Ş., Cefle K., Ozbek U., et al.
Cellular and molecular biology (Noisy-le-Grand, France)
, vol.62, no.7, pp.61-5, 2016 (SCI-Expanded)
2016
201633. Pesg PNH diagnosis, follow-up and treatment guidelines
ŞAHİN F., Akay O. M., Ayer M., Dal M. S., Ertop S., İLHAN O., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH
, vol.6, no.2, pp.19-27, 2016 (ESCI)
2016
201634. Acquired FVIII and FIX Inhibitors after Pregnancy: A Case Report.
Kose M., Bakkaloglu O. K., Amikishiyev S., Akpinar T. S., Saracoglu B., Akcan T., et al.
Acta haematologica
, vol.136, no.4, pp.229-232, 2016 (SCI-Expanded, Scopus)
2014
201435. The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience
Yenerel M. N., Aktan M., Yildiz A., Caliskan Y., Nalcaci M.
BLOOD
, vol.124, no.21, 2014 (SCI-Expanded)
2014
201436. Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management
Yenerel M. N.
TURKISH JOURNAL OF HEMATOLOGY
, vol.31, no.3, pp.216-225, 2014 (SCI-Expanded)
2013
201337. Leukemic ascites as an initial presentation of acute myelomonocytic leukemia with inversion of chromosome 16.
Yonal I., Kayar Y., Nazligul E., Yenerel M. N., Kalayoglu-Besisik S.
Annals of Saudi medicine
, vol.33, no.2, pp.197-8, 2013 (SCI-Expanded)
2012
201238. Massive ascites as the initial manifestation of mantle cell lymphoma: A challenge for the gastroenterologist
Yonal I., Ciftcibasi A., Gokturk S., Yenerel M. N., Akyuz F., Karaca C., et al.
Case Reports in Gastroenterology
, vol.6, no.3, pp.803-809, 2012 (Scopus)
2012
201239. Analysis of p53 Tumor Suppressor Pathway Genes in Chronic Lymphocytic Leukemia
Isin M., Yenerel M. N., Aktan M., Buyru N., Dalay N.
DNA AND CELL BIOLOGY
, vol.31, no.5, pp.777-782, 2012 (SCI-Expanded)
2012
201240. A case of chronic lymphocytic leukemia with massive ascites
Yonal I., Nazligul E., Tas G., Agan M. R., YENEREL M. N., NALÇACI M.
RARE TUMORS
, vol.4, no.4, pp.165-168, 2012 (ESCI)
2011
201141. Unusual presentation of adrenal lymphoma observed with PET-CT
Ozkan Z. G., Turkmen C., Sanli Y., Yenerel M. N., Adalet I.
TURKISH JOURNAL OF HEMATOLOGY
, vol.28, no.4, pp.337-338, 2011 (SCI-Expanded)
2010
201042. A case of thrombotic thrombocytopenic purpura due to clopidogrel: Case report
Kayacan S. M., Vatansever S., YENEREL M. N., Akkaya V., Kayacan D., Erk O., et al.
Turkiye Klinikleri Cardiovascular Sciences
, vol.22, no.2, pp.270-272, 2010 (Scopus)
2010
201043. NILOTINIB EFFICACY IN 21 IMATINIB-RESISTANT OR-INTOLERANT T (9;22) POSITIVE CHRONIC MYELOID LEUKEMIA PATIENTS WITH AND WITHOUT ADDITIONAL CHROMOSOMAL CHANGES
Yavuz A. S., Elcioglu O. C., Akpinar T. S., Cosan F., Ucur A., Bayrak A., et al.
NOBEL MEDICUS
, vol.6, no.2, pp.57-62, 2010 (SCI-Expanded)
2010
201044. Peritoneal seeding and subsequent progression of mantle cell lymphoma after splenectomy for debulking
Bahat G., Saka B., Yenerel M. N., Yilmaz E., Tascioglu C., Dogan O.
CURRENT ONCOLOGY
, no.3, pp.78-82, 2010 (SCI-Expanded)
2009
200945. Hyperbaric oxygen: An important treatment modality in severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
Yenerel M. N., Kalayoglu-Besisik S., Perdeci O., Gurses N., Tunc M., Sargin D.
Turkish Journal of Hematology
, vol.26, no.4, pp.176-180, 2009 (SCI-Expanded)
2009
200946. 2nd international congress on leukemia, lymphoma and myeloma
Arat M., Özsan G. H., Yenerel M. N., Cetin M., ÖZCAN M.
Expert Review of Hematology
, vol.2, no.5, pp.509-512, 2009 (Scopus)
2009
200947. Comparison of the Cytogenetic and Molecular Analyses in the Assessment of Imatinib Response in Chronic Myelocytic Leukemia
Palanduz S., Bayrak A., Sirma S., Vural B., Cefle K., Ucur A., et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, vol.13, no.5, pp.599-602, 2009 (SCI-Expanded)
2009
200948. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.
Sayitoglu M., Haznedaroğlu İ. C., Hatirnaz O., Erbilgin Y., Aksu S., Koca E., et al.
The Journal of international medical research
, vol.37, no.4, pp.1018-28, 2009 (SCI-Expanded)
2009
200949. PRESENTING CLINICAL AND LABORATORY FINDINGS OF 282 PATIENTS WITH HODGKIN'S DISEASE
Sahinoglu S., Yenerel M. N., Guvenc S., Kucukkaya R. D., Nalcaci M.
NOBEL MEDICUS
, vol.5, no.2, pp.18-23, 2009 (SCI-Expanded)
2008
200850. Sheehan's Syndrome Associated with Glanzmann's Thrombasthenia: Case Report and Literatur Review
Bayraktaroglu T., Colak N., Nalcaci M., Yenerel M. N.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
, vol.116, no.9, pp.549-553, 2008 (SCI-Expanded)
2008
200851. A case applied with decompensated heart failure findings diagnosed as primary effusion lymphoma
Yildirim N. D., Bicakci E., Elverdi T., Yenerel M. N., Kucukkaya R. D., Dogan O., et al.
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI
, vol.25, no.2, pp.152-155, 2008 (SCI-Expanded)
2008
200852. A case of paroxysmal nocturnal hemoglobinuria presenting with intra-abdominal bleeding due to splenic rupture, developing renal infarct
Uzun S., Alpay N., Öztürk G., Saka B., Yenerel M. N., Erten N., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
, no.3, pp.248-253, 2008 (SCI-Expanded)
2008
200853. Primary pulmonary lymphoma: A report of two cases
Yildirim N. D., Elverdi T., Bicakci E., Gokcen G., Yenerel M. N., Kucukkaya R. D., et al.
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI
, vol.25, no.1, pp.82-86, 2008 (SCI-Expanded)
2008
200854. Atypical M-protein localization in protein electrophoresis in a patient with multiple myeloma
Yildirim N. D., Ayer M., Hatipoglu E., Kucukkaya R. D., Yenerel M. N., Nalcaci M.
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI
, vol.25, no.1, pp.56-59, 2008 (SCI-Expanded)
2007
200755. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma
Yildirim N. D., Ayer M., Kuecuekkaya R. D., Alpay N., Mete O., Yenerel M. N., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
, vol.37, no.9, pp.704-707, 2007 (SCI-Expanded)
2007
200756. Haemophagocytosis in a patient with Crimean-Congo haemorrhagic fever
Cagatay A., Kapmaz M., Karadeniz A., Basaran S., Yenerel M. N., Yavuz S., et al.
JOURNAL OF MEDICAL MICROBIOLOGY
, vol.56, no.8, pp.1126-1128, 2007 (SCI-Expanded)
2007
200757. CLINICAL FOLLOW-UP AND TREATMENT RESPONSE OF THE 162 PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
YENEREL M. N., Atamer T., Ayer M., Yildirim N. D., Kucukkaya R. D., Yavuz A. S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, vol.70, no.1, pp.6-10, 2007 (ESCI)
2005
200558. Expression of adducin genes during erythropoiesis: A novel erythroid promoter for ADD2
Yenerel M. N., Sundell I., Weese J., Bulger M., Gilligan D.
EXPERIMENTAL HEMATOLOGY
, vol.33, no.7, pp.758-766, 2005 (SCI-Expanded)
2005
200559. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years
Kalayoglu-Besisik S., Yenerel M. N., Caliskan Y., Ozturk S., Besisik F., Sargin D.
TRANSPLANTATION PROCEEDINGS
, vol.37, no.5, pp.2285-2289, 2005 (SCI-Expanded)
2004
200460. Diffuse alveolar hemorrhage associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation
Kalayoglu Besisik S., Yenerel M. N., Diz Küçükkaya R., Çalişkan Y., Sargin D.
Turkish Journal of Haematology
, vol.21, no.4, pp.197-201, 2004 (SCI-Expanded)
2003
200361. The in vitro effect of interferon-alpha 2a on CD95 expression of T cells in hepatitis B
Karan M., Ozturk S., Yenerel M. N., Erten N., Cefle K., Palanduz S., et al.
HEPATO-GASTROENTEROLOGY
, vol.50, no.54, pp.2031-2034, 2003 (SCI-Expanded)
2003
200362. The outcome of large B-cell lymphoma evolving in a hematopoietic stem cell transplant patient during treatment of chronic graft-versus-host disease
Kalayoǧlu K., Kocaman O., Erer B., Yenerel M. N., Doǧan Ö., Sargin D.
Turkish Journal of Haematology
, vol.20, no.3, pp.171-174, 2003 (SCI-Expanded)
2003
200363. Outcome after hyperbaric oxygen treatment for cyclophosphamide-induced refractory hemorrhagic cystitis.
Kalayoglu-Besisik S., Abdul-Rahman I., Erer B., Yenerel M. N., Oguz F., Tunc M., et al.
The Journal of urology
, vol.170, no.3, pp.922, 2003 (SCI-Expanded)
2002
200264. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study
Yeneral M. N., Atamer T., YAVUZ A. F., Kucukkaya R., BEŞIŞIK S., Aktan M., et al.
ANNALS OF HEMATOLOGY
, vol.81, no.9, pp.498-503, 2002 (SCI-Expanded)
2002
200265. Favorable outcome of isolated membranous nephropathy in an allogeneic stem cell recipient
Kalayoglu-Besisik S., Yurci A., Yenerel M. N., KAZANCIOĞLU R., Turkmen A., Kilicarslan Y., et al.
BONE MARROW TRANSPLANTATION
, vol.29, 2002 (SCI-Expanded)
2002
200266. Coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in two patients presented with Budd-Chiari syndrome
Diz-Kucukkaya R., Demir K., Yenerel M. N., Nalcaci M., Kaymakoglu S., Inanc M.
HAEMATOLOGIA
, vol.32, no.1, pp.73-77, 2002 (SCI-Expanded)
2001
200167. HHV-8 is not ubiquitus in Turkish multiple myeloma patients as determined by nested-PCR and also serological analysis.
Torun A., Kalayoglu-Besisik S., Ozkan E., Basaran P., Yenerel M. N., Karan M., et al.
BLOOD
, vol.98, no.11, 2001 (SCI-Expanded)
2001
200168. Thrombotic complications in essential thrombocythemia.
Atamer T., Yenerel M. N., Yavuz A., Kucukkaya R., Besisik S., Aktan M., et al.
BLOOD
, vol.98, no.11, 2001 (SCI-Expanded)
2001
200169. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: A single center study.
Yenerel M. N., Atamer T., Yavuz A., Kucukkaya R., Besisik S., Aktan M., et al.
BLOOD
, vol.98, no.11, 2001 (SCI-Expanded)
2001
200170. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study
Diz-Kucukkaya R., hacıhanefioğlu a., Yenerel M. N., TURGUT M., Keskin H., Nalcaci M., et al.
BLOOD
, vol.98, no.6, pp.1760-1764, 2001 (SCI-Expanded)
2001
200171. Paroxysmal nocturnal hemoglobinuria clone in patients with myelodysplastic syndrome
Yenerel M. N., Diz-Kucukkaya R., Besisik S., Aktan M., Nalcaci M., Dincol G., et al.
AMERICAN JOURNAL OF HEMATOLOGY
, vol.68, no.1, pp.64-65, 2001 (SCI-Expanded)
2001
200172. CD15-expressing phagocytic plasma cells in a patient with multiple myeloma
KUCUKKAYA R., HACIHANEFIOGLU A., YENEREL M. N., TURGUT M., NALCACI M., KESKIN H., et al.
BLOOD
, vol.97, no.2, pp.581-583, 2001 (SCI-Expanded)
2000
200073. Chimerism status in allo-pbsct versus allo-BMT: single center results
Uzbek U., Kalayoglu-Besisik S., Aydin M., Yenerel M. N., Aktan M., Budak T., et al.
Blood
, vol.96, 2000 (SCI-Expanded)
2000
200074. Chimerism status in allo-PBSCT versus allo-BMT: Single center results.
Özbek U., Kalayoglu-Besısık S., Aydin M., Yenerel M. N., Aktan H., Budak T., et al.
BLOOD
, vol.96, no.11, 2000 (SCI-Expanded)
2000
200075. The influence of flow cytometric gating strategy and cell preparation procedures on CD34(+) cell quantification
Yenerel M. N., Budak-Alpdogan T., Kalayoglu-Besisik S., Yanasik M., Sargin D.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
, vol.9, no.1, pp.11-12, 2000 (SCI-Expanded)
1999
199976. Concomitant chronic lymphocytic leukemia and acute myeloid leukemia diagnosed by two color flow cytometric analysis
Yenerel M. N., HATEMİ A. İ., Keskin H.
HAEMATOLOGICA
, vol.84, no.8, pp.766-767, 1999 (SCI-Expanded)
1999
199977. Bernard-Soulier syndrome caused by a novel insertional mutation in the glycoprotein IB alpha gene
Nagel T., Kim H., Yenerel M. N., Pekcelen Y., Mahley R., Afshar-Kharghan V., et al.
THROMBOSIS AND HAEMOSTASIS
, pp.690, 1999 (SCI-Expanded)
1999
199978. Iron deficiency anemia of unknown etiology and/or resistance to the treatment: The sole manifestation of adult celiac disease (CD) [5]
YENEREL M. N., Kalayoglu-Besisik S.
American Journal of Hematology
, vol.61, no.2, pp.156-157, 1999 (SCI-Expanded)
1999
199979. Iron deficiency anemia of unknown etiology and or resistance to the treatment: The sole manifestation of adult celiac disease (CD)
Yenerel M. N., Kalayoglu-Besisik S.
AMERICAN JOURNAL OF HEMATOLOGY
, vol.61, no.2, pp.156-157, 1999 (SCI-Expanded)
1999
199980. The source of stem cells (BMT versus PBSCT) in adult allogeneic transplantation does not only predict the incidence of chronic GVHD but also the outcome of the transplant.
Besisik S., Budak T., Yenerel M. N., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION
, vol.23, 1999 (SCI-Expanded)
1998
199881. Bernard-Soulier syndrome: Differential platelet glycoprotein Ib-IX-V expression in five distinct Turkish kindreds.
Nagel T., Yenerel M. N., Diz-Kucukkaya R., Pekcelen Y., Hicsonmez G., Kim H., et al.
BLOOD
, vol.92, no.10, 1998 (SCI-Expanded)
1998
199882. High risk of chronic graft-versus-host disease in unmanipulated allogeneic peripheral blood stem cell transplantation
Kalayoglu-Besisik S., Budak-Alpdogan T., Yenerel M. N., Sargin D., Tangun Y.
BLOOD
, vol.92, no.8, pp.2973-2975, 1998 (SCI-Expanded)
1998
199883. Adult T cell acute lymphoblastic leukemia: Clinical parameters and outcome
Yenerel M. N., Nalcaci M., Aktan M., Yavuz S., Keskin H., Sargin D., et al.
BRITISH JOURNAL OF HAEMATOLOGY
, vol.102, no.1, pp.229, 1998 (SCI-Expanded)
1998
199884. Concomitant chronic lymphocytic leukemia and acute myeloid leukemia diagnosed by two color flow cytometric analysis
Yenerel M. N., Hatemi I., Keskin H.
BRITISH JOURNAL OF HAEMATOLOGY
, vol.102, no.1, pp.201, 1998 (SCI-Expanded)
1998
199885. Clinical and hematological study of 11 patients with paroxysmal nocturnal hemoglobinuria
Yenerel M. N., Nalcaca M., Atamer T., Pekcelon Y.
BRITISH JOURNAL OF HAEMATOLOGY
, vol.102, no.1, pp.307, 1998 (SCI-Expanded)
1998
199886. Thrombocytopenia in allogeneic peripheral blood stem cell transplantation (allo-PBSCT) donors.
Besisik S., Alpdogan T., Yenerel M. N., Altay S., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION
, vol.21, 1998 (SCI-Expanded)
1998
199887. Allogeneic peripheral blood stem cell transplantation (allo-PBSCT) versus allogeneic bone marrow transplantation (allo-BMT): Rapid engraftment but increased morbidity due to GVHD
Besisik S., Yenerel M. N., Alpdogan T., Yavuz A., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION
, vol.21, 1998 (SCI-Expanded)
1998
199888. Autonomic dysfunction in vitamin B12 deficiency: A heart rate variability study
Sozen A., Demirel S., Akkaya V., Kudat H., Tukek T., Yeneral M. N., et al.
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM
, vol.71, no.1, pp.25-27, 1998 (SCI-Expanded)
1998
199889. Graft versus myeloma effect augmented by donor leukocyte infusions (DLI) following an incomplete response to allogeneic blood stem cell transplantation (ALLO-BSCT): A case report.
Besisik S., Yenerel M. N., Alpdogan T., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION
, vol.21, 1998 (SCI-Expanded)
1998
199890. The value of reticulocyte maturity index (RMI) as a predictor of engraftment in allogeneic peripheral blood stem cell transplantation (allo-PBSCT)
Yenerel M. N., Besisik S., Alpdogan T., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION
, vol.21, 1998 (SCI-Expanded)
1998
199891. The influence of flow cytometric (FC) gating strategy and cell preparation procedures on CD34+ cell enumeration.
Budak-Alpdogan T., Yenerel M. N., Besisik-Kalayoglu S., Yanasik M., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION
, vol.21, 1998 (SCI-Expanded)
1997
199792. Incidence and severity of GVHD in allogeneic peripheral blood stem cell transplantation (ALLO-PBSCT). Analysis of 21 patients.
Besisik S., Yenerel M. N., Alpdogan T., Sargin D., Tangun Y.
BLOOD
, vol.90, no.10, pp.4495, 1997 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. Multipl Miyelom'da Genetik Karmaşa: Optik Genom Haritalamanın Yeri
BAYRAK TOKAÇ A. G., ERDEM S., ADAY A., MUTLU M. B., GÜNEY D. K., MASTANZADE M., et al.
12. Hematolojik Onkoloji Kongresi, KKTC, Turkey, 02 October 2025, pp.134-137, (Summary Text)
2025
20252. Kronik Lenfositik Lösemide Optik Genom Haritalamanın FISH Analizine Tamamlayıcı Rolü: Tek Merkez Pilot Çalışma
ERDEM S., BAYRAK TOKAÇ A. G., ADAY A., KARACA D., MUTLU M. B., ÇEFLE K., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 02 November 2025, pp.121-122, (Summary Text)
2025
20253. Bir Taşla İki Kuş: Akalabrutinib ile KLL ve Anjiyoödem Kontrolü
SARAÇ Z., ERDEM S., KORUK K., MASTANZADE M., HÖRMET İĞDE M., YEĞİT O. O., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October 2025, pp.337-338, (Summary Text)
2025
20254. Yeni Tanı Multipl Miyelomda Tromboz Riskinin Öngörülmesi: 589 Hastalık Gerçek Yaşam Deneyimi
MASTANZADE M., HASANZADE U., İNAN N. Y., TAHA F. J., EMEL P., ERDEM S., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October 2025, pp.191, (Summary Text)
2025
20255. Multipl Myelomda lenalidomidin beklenmeyen yüzü: Lökositoklastik vaskülit
AKIN A., KILIÇ İ., KORUK K., ERDEM S., YENEREL M. N.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.58, (Summary Text)
2025
20256. The Silent Threat of Secondary Malignancies in Multiple Myeloma Patients: A Cohort Study from Turkey in the Era of New Drugs
Mastanzade M., Taha F. J., Hasanzade U., İnan N. Y., Zeynallı B., Ören Çelik M. M., et al.
The 11th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy), Paris, France, 15 May 2025, (Summary Text)
2024
20247. A Single-Center Real-Life Experience with First-Line Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (DARA-VCD) in AL Amyloidosis
MASTANZADE M., ÖREN ÇELİK M. M., ERDEM S., ÖZBALAK M. M., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Hematoloji Uzmanlık Derneği 18. Ulusal Kongresi, Antalya, Turkey, 21 - 24 November 2024, vol.46, pp.26-27, (Summary Text)
2024
20248. Optical Genome Mapping in Newly Diagnosed Chronic Lymphocytic Leukemia
ERDEM S., BAYRAK TOKAÇ A. G., ADAY A., KARACA D., ÖZTÜRK Ş., ÇEFLE K., et al.
66th ASH Annual Meeting and Exposition, San Diego, CA, United States Of America, 7 - 10 December 2024, pp.6758, (Summary Text)
2024
20249. Akut Miyeloid Lösemide İzositrat Dehidrogenaz 1 (IDH1) Gen Mutasyonu Sıklığı ve Klinik: Tek Merkez Deneyimi
ÇATMA Y., ERDEM S., ADAY A., MASTANZADE M., ÖZBALAK M. M., YÖNAL HİNDİLERDEN İ., et al.
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.228, (Summary Text)
2023
202310. Multipl miyelomda kemik iliği fibrozisinin ekstramedüller hastalık ile ilişkisi
Konyaoğlu H., Altay A. Y., Işık E. G., Oluk B., Taghiyeva N., Sakcı E., et al.
25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.77-78, (Full Text)
2023
202311. The relationship of bone marrow fibrosis with extramedullary disease in multiple myeloma
Konyaoğlu H., Altay A. Y., Işık E. G., Oluk B., Taghiyeva N., Sakcı E., et al.
28th Congress of the European Hematology Association (EHA 2023), Frankfurt, Germany, 08 June 2023, pp.1776, (Summary Text)
2023
202312. The role of 18F-FDG PET/CT Scan in adult langerhans cell histiocytosis: A single center experience
ERDEM S., ÇETİN O., KIRAN M. Y., IŞIK E. G., BEYAZ BELKAYA Ş., YEGEN G., et al.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 5 - 07 May 2023, pp.40-41, (Summary Text)
2023
202313. Insight into hypereosinophilia from the hematology clinic; A single-center experience
OLUK B., TAGHİYEVA N., SAKCI E., ERDEM S., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.64, (Summary Text)
2023
202314. Covid vaccination associated acquired thrombotic thrombocytopenic purpura
SİLAY R., TAGHİYEVA N., ERDEM S., YENEREL M. N.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.52, (Summary Text)
2022
202215. GRAVES HASTALIĞI VE DİFFÜZ BÜYÜK B HÜCRELİ LENFOMA BİRLİKTELİĞİ
Kıkılı C. İ., SARIBEYLİLER G., ALTINKAYNAK M., ERDEM S., KUBAT ÜZÜM A., YENEREL M. N.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.112-113, (Full Text)
2022
202216. Multipl miyelom dışı plazma hücre hastalıklarında kök hücre desteği ile yüksek doz kemoterapi deneyimi
TİRYAKİ T. O., YÖNAL HİNDİLERDEN İ., ERDEM S., MASTANZADE M., ÖZBALAK M. M., OLUK B., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.196-197, (Summary Text)
2022
202217. Kronik lenfositer lösemi olgularının tanı sırasındaki T lenfosit alt gruplarının prognoz üzerine etkisi
SEYİTHANOĞLU D., NAZLIGÜL SERT E., ERDEM S., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.145-146, (Summary Text)
2022
202218. Kronik lenfositik lösemi tanısında FCRL gen ailesi ekspresyon seviyelerinin araştırılması
ÇOŞKUNPINAR E. M., GÜNDÜZ K., ERDEM S., YENEREL M. N.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.149-150, (Summary Text)
2022
202219. Kronik lenfositik lösemi hastalarında tanısal parametrelerin değerlendirilmesi
GÜNDÜZ K., ÇOŞKUNPINAR E. M., ERDEM S., YENEREL M. N.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.293, (Summary Text)
2022
202220. Büyük granüllü lenfosit artışı olan olguların tanısında immünfenotiplemenin rolü: Tek merkez deneyimi
NAZLIGÜL SERT E., TİRYAKİ T. O., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., ERDEM S., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.199-200, (Summary Text)
2021
202121. WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
ERDEM S., MASTANZADE M., ÖZBALAK M. M., KUBİLAY D. Ö., TİRYAKİ T. O., OLUK B., et al.
XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.96, (Summary Text)
2021
202122. Yeni tanı DBBHL’de biyobenzer rituksimab (Redditux) içeren R-CHOP rejimi sonuçları: Tek merkez gerçek yaşam deneyimi
ÖZBALAK M. M., MASTANZADE M., KUBİLAY D. Ö., TİRYAKİ T. O., ERDEM S., Pınar Özbalak E., et al.
47. Ulusal Hematoloji Kongresi, Antalya, Turkey, 04 November 2021, (Full Text)
2021
202123. R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience
Özbalak M. M., Mastanzade M., Özlük Ö., Tiryaki T. O., Erdem S., Özbalak E. P., et al.
63rd ASH Annual Meeting and Exposition, Georgia, United States Of America, 11 - 14 December 2021, pp.4585, (Summary Text)
2021
202124. A raman tweezer study with single red blood cells for the diagnosis of paroxysmal nocturnal hemoglobinuria
Parlatan S., Parlatan U., Soysal K. B., Mastanzade M., Ozbalak M. M., Yenerel M. N., et al.
Optical Molecular Probes, Imaging and Drug Delivery, OMP 2021 - Part of Biophotonics Congress: Optics in the Life Sciences 2021, Virtual, Online, United States Of America, 12 - 16 April 2021, (Full Text)
2021
202125. Dual-Beam optical Manipulation of Red blood cells for the investigation of paroxysmal nocturnal hemoglobinuria
Parlatan U., Soysal K. B., Parlatan S., Mastanzade M., Ozbalak M. M., Yenerel M. N., et al.
Optical Manipulation and Its Applications, OMA 2021 - Part of Biophotonics Congress: Optics in the Life Sciences 2021, Virtual, Online, United States Of America, 12 - 16 April 2021, (Full Text)
2020
202026. Steroide duyarlı kronik anemisi ve osteosklerozu olan erişkin olguda moleküler tanının klinik izleme etkisi
Sharifi S., Kalaycı T., Kaya M., SUER İ., ÖZTÜRK Ş., ÇEFLE K., et al.
14. Ulusal Tıbbi Genetik Kongresi (Uluslararası katılımlı), Turkey, 20 - 23 November 2020, pp.37, (Summary Text)
2020
202027. Prognostic value of pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratio in diffuse large B-cell lymphoma: a single-center experience
Dağcı G., Mastanzade M., Özbalak M. M., Kubilay D. Ö., Tiryaki T. O., Yönal Hindilerden İ., et al.
XIth Eurasian Hematology Oncology Congress, İstanbul, Turkey, 21 - 24 October 2020, no.42, pp.48-49, (Summary Text)
2020
202028. MİKROANJİYOPATİK HEMOLİTİK ANEMİNİN GEÇ GELİŞTİĞİ BİR ATİPİK HEMOLİTİK ÜREMİK SENDROM VAKASI
Gülseren Ü. A., DENİZ R., ALTINKAYNAK M., YAZICI H., YENEREL M., ERTEN S. N., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme 2020, Sakarya, Turkey, 12 March 2020, pp.165, (Full Text)
2019
201929. Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey
KEKLİK KARADAĞ F., Yenerel M. N., Mehmet Y., Teke H. U., Ozkocaman V., Tuglular T., et al.
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134, (Summary Text)
2019
201930. A retrospective analysis of peripheral T-cell lymphoma patients: single-center 'real-life' experience
Ozbalak M. M., Besisik S., Mastanzade M., Ozluk O., Ozmen A., Hindilerden I. Y., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)
2019
201931. The efficacy of reuse therapeutic plasma exchange in relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a single-center experience of 130 cases
Mastanzade M., Besisik S., Dadin S. A., Aktan M., Hindilerden I. Y., Yenerel M. N., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)
2018
201832. The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study
Yenerel M. N., Erdem S., Mastanzade M., Nalcaci M.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text)
2018
201833. Akut Myeloid Lösemi ve 3q Kromozomal Yeniden Düzenlenmeleri
Bagatir G., Kaya M., Dön B., SUER İ., NALÇACI M., YENEREL M. N., et al.
3. Ulusal Uygulamalı Biyolojik Bilimler Kongresi (UBBK), Eskişehir, Turkey, 3 - 05 May 2018, vol.1, pp.35, (Summary Text)
2017
201734. The Whole Exome Analysis and Clinical Relevance in Patients with Atypical Hemolytic Uremic Syndrome
Yenerel M. N., Caliskan Y., Yildiz A., Karadeniz S., Turkmen A., Kayacan M. S., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)
2017
201735. RNA sequencing and in silico analysis of Myeloma cells in multiple myeloma patients
Sarıman M., SIRMA EKMEKCİ S., ABACI N., ÇAKİRİS A., PAÇAL F., ÜSTEK D., et al.
XV.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Fethiye- Muğla, Turkey, 26 - 29 October 2017, pp.108, (Summary Text)
2017
201736. Yine yeniden Hodgkin lenfoma olguları: Nüks mü ikincil kanser mi?
Erdem S., Demir N., Özkan S. G., Yenerel M. N., Yeğen G., Doğan İ. Ö., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.156, (Summary Text)
2017
201737. Multiple Myeloma hastalarının Myeloma hücrelerinde RNA dizileme ve in-silico analizler.
Sarıman M., Sırma Ekmekci S., Abacı N., Çakiris A., Perçin Paçal F., Üstek D., et al.
XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Fethiye, Muğla, Turkey, 26 October 2017, (Unpublished)
2017
201738. Multiple Myeloma hastalarının Myeloma hücrelerinde RNA dizileme ve insilico analizler.
Sarıman M., Sırma Ekmekci S., Abacı N., Çakiris A., Paçal F., Üstek D., et al.
XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi , Muğla, Turkey, 26 - 29 October 2017, pp.108-109, (Summary Text)
2016
201639. Investigation of gene expression of myeloma cells in bone marrow of multiple myeloma patients by transcriptome analysis
Sarıman M., SIRMA EKMEKCİ S., ABACI N., ÇAKİRİS A., PAÇAL F., ÜSTEK D., et al.
ESHG 2016, Barcelona, Spain, 21 - 24 May 2016, pp.153, (Full Text)
2016
201640. USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY
Cekdemir D., Ozdemirkiran F., Guvenc S., Eser A., Ozkocaman V., Sahin H. H., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Turkey, 4 - 07 May 2016, vol.141, (Summary Text)
2015
201541. Patients with Paroxysmal Nocturnal Hemoglobinuria and Hemolysis Demonstrate More Frequent Disease-Related Features Than Those without Hemolysis, but Similar Proportions Experience Thromboembolism
Yenerel M. N., Muus P., Wilson A., Szer J.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text)
2015
201542. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria
Erkek E. T., Nazligul E., Nalcaci M., Aktan M., Yenerel M. N.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text)
2015
201543. ACI LDE ZOR VAKALAR ZOR KARARLAR
KÖSE M., GÜLER K., YENEREL M. N., TÜKEK T.
17. Ulusal İç Hastalıkları Kongresi, Turkey, 14 - 18 October 2015
2015
201544. Hasta ortada kalmasın Multidisipliner yaklaşım
TÜKEK T., TANAKOL R., KAYMAKOĞLU S., YENEREL M. N., KÖSE M.
"Geleneksel İç Hastalıkları Günleri-İnteraktif Güncelleştirme - 2016", Turkey, 11 - 13 March 2015
2014
201445. VAKALARLA ACI LDE KANAMALI HASTAYA YAKLAS IM
TÜKEK T., YENEREL M. N., KÖSE M.
16. Ulusal İç Hastalıkları Kongresi, Turkey, 15 - 19 October 2014
2010
201046. ZBTB7A AND BCL6 GENES ARE NOT EXPRESSED IN CLL
Isin M., Yenerel M. N., Aktan M., Buyru N., Dalay N.
38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Germany, 3 - 08 September 2010, vol.31, (Summary Text)
2009
200947. The evaluation of the genomic instability by micronucleus and sister chromatid exchange in myelodysplastic syndrome
Nazligul E., Palanduz P., Ozturk O., Bayrak A., Ucur A., Bagatir G., et al.
7th European Cytogenetics Conference, Stockholm, Sweden, 4 - 07 July 2009, vol.17, pp.137-138, (Summary Text)
2009
200948. Kronik Lenfositik Lösemili Hastalarda p53 P14ARF ve HDM2 Gen İfade Düzeyleri
IŞIN M., YENEREL M. N., AKTAN M., BUYRU A. N., DALAY N.
XVIII. Ulusal Kanser Kongresi, Antalya, Antalya, Turkey, 21 - 26 April 2009, pp.194, (Full Text)
2006
200649. Does previous interferon use have negative effect on imatinib response in chronic myeloid leukemia (CML)? A single center study.
Yenerel M. N., Diz-Kucukkaya R., Demirel N., Ayer M., Yavuz S., Besisik S., et al.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)
2003
200350. The association of HLA class I antigens and class II alleles with multiple myeloma in Turkey.
Kalayoglu-Besisik S., Erer B., Savran-Oguz F., Yucel S., Erten N., Yenerel M. N., et al.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text)
2003
200351. beta-adducin gene expression is suppressed during megakaryopoiesis.
Sundell-Ranby B., Yenerel M. N., Shim M., Reems J., Gilligan D.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text)
2002
200252. Differential expression of adducin mRNAs during erythropoiesis.
Yenerel M. N., Sundell B., Gilligan D.
44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 December 2002, vol.100, (Summary Text)
2000
200053. Myeloid/Natural Killer Cell Acute Leukemia: A Case Report
Turgut M., GELİNCİK A., YENEREL M. N., Köroğlu G., AKTAN M., Pekçelen Y.
5th Annual Meeting of The European Haematology Association, Birmington, United Kingdom, 25 - 28 June 2000, pp.106, (Full Text)
Funded Projects
2015 - 2017
2015 - 2017ATİPİK HEMOLİTİK ÜREMİK SENDROMLU HASTALARDA KOMPLEMAN MUTASYONLARININ ARAŞTIRILMASI
Project Supported by Higher Education Institutions , BAP Research Project
YENEREL M. N. (Executive)
Congress and Symposium Activities
11 October 2023 - 14 October 2023
11 October 2023 - 14 October 2023XIV. Eurasian Hematology oncology congress
Invited Speaker
İstanbul-Turkey
11 October 2023 - 14 October 2023
11 October 2023 - 14 October 2023XIV. eurasian hematology oncology congress
Moderator
İstanbul-Turkey
07 October 2023 - 07 October 2023
07 October 2023 - 07 October 2023TSH-ISH joint course on hematological malignancies
Invited Speaker
İstanbul-Turkey
28 September 2023 - 30 September 2023
28 September 2023 - 30 September 202310.HEMATOLOJİK ONKOLOJİ KONGRESİ
Session Moderator
Girne-Cyprus (Kktc)
22 September 2023 - 24 September 2023
22 September 2023 - 24 September 202312. Ulusal Geriatrik Hematoloji Kongresi’
Panelists
Ankara-Turkey
16 September 2023 - 16 September 2023
16 September 2023 - 16 September 2023AKUT LÖSEMİ ÇALIŞTAYI
Moderator
Sinop-Turkey
14 September 2023 - 17 September 2023
14 September 2023 - 17 September 202310. AAEGEAN HEMATOLOGY ONCOLOGY SYMPOSİUM
Session Moderator
İstanbul-Turkey
02 September 2023 - 02 September 2023
02 September 2023 - 02 September 2023ŞİKAGO, FRANKFURT VE ROMADA NELER ÖĞRENDİK
Moderator
Ankara-Turkey
26 May 2023 - 28 May 2023
26 May 2023 - 28 May 202311. Bozyaka Hematoloji Sempozyumu
Invited Speaker
İzmir-Turkey
18 May 2023 - 19 May 2023
18 May 2023 - 19 May 20231st International IPIG Conference
Invited Speaker
Manchester-England
15 May 2023 - 15 May 2023
15 May 2023 - 15 May 2023PAROKSİSMAL NOKTURNAL HEMOGLOBİNURİ
Invited Speaker
İstanbul-Turkey
05 May 2023 - 06 May 2023
05 May 2023 - 06 May 20231th Annual Meet The Experts of Transplantation and Myeloma: EBMT and TCT” congress
Session Moderator
Antalya-Turkey
27 April 2023 - 30 April 2023
27 April 2023 - 30 April 2023